AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 292: E802-E811, 2007. First published November 14, 2006; doi:10.1152/ajpendo.00369.2006
0193-1849/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/3/E802    most recent
00369.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barré, L.
Right arrow Articles by Witters, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barré, L.
Right arrow Articles by Witters, L. A.

Genetic model for the chronic activation of skeletal muscle AMP-activated protein kinase leads to glycogen accumulation

Laura Barré,1,* Christine Richardson,1,* Michael F. Hirshman,2 Joseph Brozinick,3 Steven Fiering,1 Bruce E. Kemp,4 Laurie J. Goodyear,2 and Lee A. Witters1

1Departments of Medicine, Biochemistry, and Microbiology and Immunology, Dartmouth Medical School, and Department of Biological Sciences, Dartmouth College, Hanover, New Hampshire; 2Research Division, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts; 3Eli Lilly and Co., Indianapolis, Indiana; 4St. Vincent's Institute and CSIRO Molecular and Health Technologies, Fitzroy, Victoria, Australia

Submitted 24 July 2006 ; accepted in final form 13 November 2006

The AMP-activated protein kinase (AMPK) is an important metabolic sensor/effector that coordinates many of the changes in mammalian tissues during variations in energy availability. We have sought to create an in vivo genetic model of chronic AMPK activation, selecting murine skeletal muscle as a representative tissue where AMPK plays important roles. Muscle-selective expression of a mutant noncatalytic {gamma}1 subunit (R70Q{gamma}) of AMPK activates AMPK and increases muscle glycogen content. The increase in glycogen content requires the presence of the endogenous AMPK catalytic {alpha}-subunit, since the offspring of cross-breeding of these mice with mice expressing a dominant negative AMPK{alpha} subunit have normal glycogen content. In R70Q{gamma}1-expressing mice, there is a small, but significant, increase in muscle glycogen synthase (GSY) activity associated with an increase in the muscle expression of the liver isoform GSY2. The increase in glycogen content is accompanied, as might be expected, by an increase in exercise capacity. Transgene expression of this mutant AMPK{gamma}1 subunit may provide a useful model for the chronic activation of AMPK in other tissues to clarify its multiple roles in the regulation of metabolism and other physiological processes.

glycogen synthase; exercise; transgenic mice



Address for reprint requests and other correspondence: L. A. Witters, Dartmouth Medical School, Remsen 322, N. College St., Hanover, NH 03755-3833 (e-mail: lee.a.witters{at}dartmouth.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. D. Folmes, L. A. Witters, M. F. Allard, M. E. Young, and J. R. B. Dyck
The AMPK {gamma}1 R70Q mutant regulates multiple metabolic and growth pathways in neonatal cardiac myocytes
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3456 - H3464.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.